Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherShort Communication

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase

Mariko Nakano, Edward J. Kelly and Allan E. Rettie
Drug Metabolism and Disposition November 2009, 37 (11) 2119-2122; DOI: https://doi.org/10.1124/dmd.109.028530
Mariko Nakano
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward J. Kelly
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allan E. Rettie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 11 2119-2122
DOI 
https://doi.org/10.1124/dmd.109.028530
PubMed 
19661213

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received May 19, 2009
  • Accepted August 3, 2009
  • Published online October 16, 2009.

Article Versions

  • Earlier version (August 6, 2009 - 07:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Mariko Nakano,
  2. Edward J. Kelly and
  3. Allan E. Rettie
  1. Departments of Medicinal Chemistry (M.N., A.E.R.) and Pharmaceutics (E.J.K.), School of Pharmacy, University of Washington, Seattle, Washington
  1. Address correspondence to:
    Allan E. Rettie,Department of Medicinal Chemistry, Box 357610, School of Pharmacy, University of Washington, Seattle, WA 98195-7610. E-mail: rettie{at}u.washington.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 20171186
Sep 20176147
Oct 201732610
Nov 20173174
Dec 20172177
Jan 20184174
Feb 20185317
Mar 20182224
Apr 20182276
May 20180275
Jun 20182388
Jul 201802110
Aug 20180155
Sep 20180219
Oct 20180172
Nov 20180149
Dec 20181753
Jan 20191044
Feb 20191644
Mar 20192021
Apr 20192327
May 201935510
Jun 20191737
Jul 20192026
Aug 20191515
Oct 20192743
Nov 20192755
Dec 20193012
Jan 20202545
Feb 20201344
Mar 2020810
May 20204532
Jun 20201512
Jul 20201212
Aug 20202204
Sep 20202325
Oct 20202559
Nov 20202116
Dec 20201832
Jan 20212665
Feb 20212182
Mar 20213721
Apr 2021933
May 20211641
Jun 20212362
Jul 20212613
Aug 20212312
Sep 202114104
Oct 20211521
Nov 20211912
Dec 20212810
Jan 20222763
Feb 20221411
Mar 20221810
Apr 2022731
May 20222233
Jun 20223111
Jul 20222129
Aug 20222911
Sep 20222342
Oct 20221541
Nov 20224127
Dec 20222976
Jan 20234452
Feb 20231535
Mar 20232040
Apr 20231484
May 20233333

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (11)
Drug Metabolism and Disposition
Vol. 37, Issue 11
November 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherShort Communication

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase

Mariko Nakano, Edward J. Kelly and Allan E. Rettie
Drug Metabolism and Disposition November 1, 2009, 37 (11) 2119-2122; DOI: https://doi.org/10.1124/dmd.109.028530

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherShort Communication

Expression and Characterization of CYP4V2 as a Fatty Acid ω-Hydroxylase

Mariko Nakano, Edward J. Kelly and Allan E. Rettie
Drug Metabolism and Disposition November 1, 2009, 37 (11) 2119-2122; DOI: https://doi.org/10.1124/dmd.109.028530
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communications

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics